Point of Care diagnostics don't tend to get as much love as their flashier, lab-based cousins. We expect that the enthusiasm for POC may pick up soon, however. POC tests have already had a significant impact on health economics and the practice of medicine. As current trends continue, we believe their role will continue to expand.
That's why we're proud to sponsor a new eBook from Fierce Medical Devices: Point-of-care diagnostics: How the industry is moving forward in the face of surging demand. It's a free downlod, but worth much more than the purchase price.
POC tests are known for their promise to deliver speed, convenience and reduced costs. But POC holds the potential to do much more than that. They might help move diagnostic activity back onto validated methods and away from research-use equipment and methods. They might help us move diagnostic activity out of high-overhead facilities and into low-intensity clinics, even retail.
To realize this future of lower-cost, higher-value testing, we're going to need to address some regulatory challenges. Chief among these is the current confusion as to which analytes may be considered eligible for a CLIA Waiver. We contributed some thoughts on that to the book and welcome your thoughts and feedback.